Skip to main content

Table 1 Demographic and clinical features of the recruited SCA3 patients

From: Abnormal eye movements in spinocerebellar ataxia type 3

Variable Cross-sectional study
  (n = 74)
Sex (male,%) 39 (52.7%)
Mean age (years) 45.04 ± 11.97
Age of onset (years) 38.79 ± 12.53
Disease duration (years) 6.25 ± 6.24
Educational year 10.53 ± 4.52
BMI 23.69 ± 21.46
Hyperreflexia (%) 33 (44.6%)
Vision loss 24 (32.4%)
ICARS-I 12.27 ± 6.71
ICARS-II 15.69 ± 8.97
ICARS-III 1.95 ± 1.53
ICARS-IV 2.24 ± 1.40
Total ICARS score 32.15 ± 16.31
SARA score 11.01 ± 5.73
MoCA score 23.58 ± 4.68
HDRS-24 score 8.80 ± 8.92
HARS score 6.82 ± 7.04
ESS score 5.41 ± 4.67
PSQI score 7.23 ± 4.46
CAG repeat length 66.07 ± 11.15
  1. SCA3 spinocerebellar ataxia 3; BMI body mass index; ICARS International Cooperative Ataxia Rating Scale; SARA Scale for the Assessment and Rating of Ataxia; MoCA, Montreal Cognitive Assessment; HDRS-24 Hamilton Depression Scale; HARS Hamilton Anxiety Scale; ESS Epworth Sleepiness Scale; PSQI Pittsburgh sleep quality index